Evaluation of the serum visfatin eotaxin and fetuin-A levels of patients with type 2 diabetes mellitus

[ X ]

Tarih

2022

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

MediHealth Academy Yayıncılık

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Objective: The aim of this study was to determine the serum visfatin, eotaxin and fetuin-A levels in patients with normal BMI and overweight type 2 diabetes mellitus (T2DM). Material and Method: This study perform in 30 T2DM patients and in 20 healthy subjects. Test subjects were divided into four groups as two diabetics and two controls. Diabetics with a body mass index (BMI) of 26.2-29.9 kg/m2 were included in the overweight diabetic group (OD), and those with a body mass index of 20.9-24.9 kg/m2 were included in the normal BMI diabetic group (ND). The volunteers in the control group were also divided into two groups as overweight (OC) and normal BMI (NC). Smoking and alcohol users were not included in the study. In addition, patients with significant diabetic complications such as retinopathy, hypertension, neuropathy, renal failure, and cardiovascular disease were excluded from the study. The serum visfatin eotaxin and fetuin-A levels were measured using the ELISA method. The Mann-Whitney U test was used to compare the data of the groups, while Spearman’s analysis was applied for the correlations. Results: The visfatin levels of the OD and ND were significantly higher compared to those of their control groups (p

Açıklama

15.TIP.018 nolu proje

Anahtar Kelimeler

Visfatin, eotaxin, fetuin-A, type 2 diabetes mellitus

Kaynak

Anatolian Current Medical Journal

WoS Q Değeri

Scopus Q Değeri

Cilt

4

Sayı

1

Künye